SAPHO syndrome with Takayasu arteritis successfully treated with tofacitinib
International Journal of Rheumatic Diseases · 2023
DOI: 10.1111/1756-185x.14628 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Rheumatic Diseases, 2023. Verfasst von Chen Ru und 6 weiteren Autor:innen. Beteiligte Einrichtung: Beijing University of Chinese Medicine, Beijing, China. Hauptthemen laut MEDLINE: Acquired Hyperostosis Syndrome, Takayasu Arteritis, Osteitis, Hyperostosis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: National Natural Science Foundation of China(No.82074246), the construction project of a critical clinical specialty in the Fengtai district of Beijing.
Abstract (Originalsprache)
SAPHO syndrome is an autoinflammatory disease with a variety of clinical manifestations, which may be accompanied by other systemic inflammatory diseases in addition to the typical manifestations of common synovitis, acne, pustulosis, hyperostosis, and osteitis. Here, we report the first case of SAPHO syndrome combined with Takayasu arteritis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing University of Chinese Medicine, Beijing, China.
- Department of Rheumatology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China.
- Department of Rheumatology, Fangshan Hospital Beijing University of Chinese Medicine, Beijing, China.
ORCID-Profile: Xiujuan Hou, Chen Li
Förderung
- National Natural Science Foundation of China(No.82074246)
- the construction project of a critical clinical specialty in the Fengtai district of Beijing
Zitieren
APA
Ru, C., Qian, T., Liu, X., Wang, C., Li, W., Hou, X., & Li, C. (2023). SAPHO syndrome with Takayasu arteritis successfully treated with tofacitinib. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.14628
Vancouver
Ru C, Qian T, Liu X, Wang C, Li W, Hou X, et al. SAPHO syndrome with Takayasu arteritis successfully treated with tofacitinib. International Journal of Rheumatic Diseases. 2023. doi:10.1111/1756-185x.14628
BibTeX
@article{Ru2023,
author = {Ru, Chen and Qian, Tangliang and Liu, Xiaoping and Wang, Chaoxin and Li, Weizhong and Hou, Xiujuan and Li, Chen},
title = {SAPHO syndrome with Takayasu arteritis successfully treated with tofacitinib},
journal = {International Journal of Rheumatic Diseases},
year = {2023},
doi = {10.1111/1756-185x.14628}
}
EUVIMED